Virus-A-Tak
Natural health product licensed in Canada
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80031828
- Status
- Active licence
- Licence date
- 30 April 2012
- Revision date
- 24 November 2012
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Astragalus membranaceus Source : Racine Extraction ratio : 7.2:1 Dry plant equivalent : 13 mg | 1.81 mg | Not calculated |
| Glycyrrhiza glabra Source : Racine Extraction ratio : 7.2:1 Dry plant equivalent : 5 mg | 0.7 mg | Not calculated |
| Ganoderma lucidum Source : Corps fructifère Extraction ratio : 7.2:1 Dry plant equivalent : 20 mg | 2.77 mg | Not calculated |
Non-medicinal ingredients
Lécithine, Carob, Eau purifiée, Amidon, Gélatine, Glycérine, Huile végétale, silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Gélule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help fight off infections, especially of the upper respiratory tract Supportive therapy in the treatment of upper respiratory tract infections (e.g. common colds). Helps to relieve the symptoms and shorten the duration of upper respiratory tract infections.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80031828
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2012. Photograph the packaging to check whether it has changed. Photograph the packaging